Literature DB >> 23022214

Nucleus Accumbens 1, a Pox virus and Zinc finger/Bric-a-brac Tramtrack Broad protein binds to TAR DNA-binding protein 43 and has a potential role in Amyotrophic Lateral Sclerosis.

M D Scofield1, L Korutla, T G Jackson, P W Kalivas, S A Mackler.   

Abstract

Protein degradation is a critical component of cellular maintenance. The intracellular translocation and targeting of the Ubiquitin Proteasome System (UPS) differentially coordinates a protein's half-life and thereby its function. Nucleus Accumbens 1 (NAC1), a member of the Pox virus and Zinc finger/Bric-a-brac Tramtrack Broad complex (POZ/BTB) family of proteins, participates in the coordinated proteolysis of synaptic proteins by mediating recruitment of the UPS to dendritic spines. Here we report a novel interaction between NAC1 and TAR DNA-binding protein 43 (TDP-43), a protein identified as the primary component of ubiquitinated protein aggregates found in patients with Amyotrophic Lateral Sclerosis (ALS). In vitro translated full-length TDP-43 associated with both the POZ/BTB domain and the non-POZ/BTB domain of NAC1 in GST pulldown assays. Other POZ/BTB proteins (including zinc finger POZ/BTB proteins and atypical POZ/BTB proteins) showed weak interactions with TDP-43. In addition, NAC1 and TDP-43 were present in the same immunocomplexes in different regions of mouse brain and spinal cord. In primary spinal cord cultures, TDP-43 expression was mainly nuclear, whereas NAC1 was both nuclear and cytoplasmic. In order to mimic ALS-like toxicity in the spinal cord culture system, we elevated extracellular glutamate levels resulting in the selective loss of motor neurons. Using this model, it was found that glutamate toxicity elicited a dose-dependent translocation of TDP-43 out of the nucleus of cholinergic neurons and increased the co-localization of NAC1 and TDP-43. These findings suggest that NAC1 may function to link TDP-43 to the proteasome; thereby, facilitating the post-translational modifications of TDP-43 that lead to the development of ALS.
Copyright © 2012 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23022214      PMCID: PMC3505276          DOI: 10.1016/j.neuroscience.2012.09.043

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  45 in total

1.  Differences in expression, actions and cocaine regulation of two isoforms for the brain transcriptional regulator NAC1.

Authors:  L Korutla; P J Wang; D M Lewis; J H Neustadter; M F Stromberg; S A Mackler
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

2.  The polar T1 interface is linked to conformational changes that open the voltage-gated potassium channel.

Authors:  D L Minor; Y F Lin; B C Mobley; A Avelar; Y N Jan; L Y Jan; J M Berger
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

3.  Structure of the human Nac1 POZ domain.

Authors:  Mark A Stead; Stephen B Carr; Stephanie C Wright
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-04-24

4.  The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy.

Authors:  P Bomont; L Cavalier; F Blondeau; C Ben Hamida; S Belal; M Tazir; E Demir; H Topaloglu; R Korinthenberg; B Tüysüz; P Landrieu; F Hentati; M Koenig
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

Review 5.  TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies.

Authors:  Todd J Cohen; Virginia M Y Lee; John Q Trojanowski
Journal:  Trends Mol Med       Date:  2011-07-23       Impact factor: 11.951

6.  Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity.

Authors:  Yong-Jie Zhang; Ya-Fei Xu; Casey Cook; Tania F Gendron; Paul Roettges; Christopher D Link; Wen-Lang Lin; Jimei Tong; Monica Castanedes-Casey; Peter Ash; Jennifer Gass; Vijayaraghavan Rangachari; Emanuele Buratti; Francisco Baralle; Todd E Golde; Dennis W Dickson; Leonard Petrucelli
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-21       Impact factor: 11.205

7.  Characterization of chronic glutamate-mediated motor neuron toxicity in organotypic spinal cord culture prepared from ALS model mice.

Authors:  Yasuhiro Kosuge; Kayo Sekikawa-Nishida; Hiroko Negi; Kumiko Ishige; Yoshihisa Ito
Journal:  Neurosci Lett       Date:  2009-03-11       Impact factor: 3.046

8.  Potentiation of amyotrophic lateral sclerosis (ALS)-associated TDP-43 aggregation by the proteasome-targeting factor, ubiquilin 1.

Authors:  Sang Hwa Kim; Yuling Shi; Keith A Hanson; Leah M Williams; Ryo Sakasai; Michael J Bowler; Randal S Tibbetts
Journal:  J Biol Chem       Date:  2008-12-26       Impact factor: 5.157

Review 9.  Molecular neuropathology of TDP-43 proteinopathies.

Authors:  Manuela Neumann
Journal:  Int J Mol Sci       Date:  2009-01-09       Impact factor: 6.208

10.  Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping.

Authors:  E Buratti; T Dörk; E Zuccato; F Pagani; M Romano; F E Baralle
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

View more
  4 in total

Review 1.  Fungal Neurotoxins and Sporadic Amyotrophic Lateral Sclerosis.

Authors:  Peter W French; Russell Ludowyke; Gilles J Guillemin
Journal:  Neurotox Res       Date:  2018-12-05       Impact factor: 3.911

2.  Unclassified low grade spindle cell sarcoma with storiform pattern characterized by recurrent novel EWSR1/FUS-NACC1 fusions.

Authors:  Cristina R Antonescu; Brendan C Dickson; Lei Zhang; Yun-Shao Sung; Christopher D Fletcher
Journal:  Mod Pathol       Date:  2021-04-15       Impact factor: 7.842

Review 3.  Microbial Infections Are a Risk Factor for Neurodegenerative Diseases.

Authors:  Sarah K Lotz; Britanie M Blackhurst; Katie L Reagin; Kristen E Funk
Journal:  Front Cell Neurosci       Date:  2021-07-07       Impact factor: 5.505

4.  A Recurrent De Novo Variant in NACC1 Causes a Syndrome Characterized by Infantile Epilepsy, Cataracts, and Profound Developmental Delay.

Authors:  Kelly Schoch; Linyan Meng; Szabolcs Szelinger; David R Bearden; Asbjorg Stray-Pedersen; Oyvind L Busk; Nicholas Stong; Eriskay Liston; Ronald D Cohn; Fernando Scaglia; Jill A Rosenfeld; Jennifer Tarpinian; Cara M Skraban; Matthew A Deardorff; Jeremy N Friedman; Zeynep Coban Akdemir; Nicole Walley; Mohamad A Mikati; Peter G Kranz; Joan Jasien; Allyn McConkie-Rosell; Marie McDonald; Stephanie Burns Wechsler; Michael Freemark; Sujay Kansagra; Sharon Freedman; Deeksha Bali; Francisca Millan; Sherri Bale; Stanley F Nelson; Hane Lee; Naghmeh Dorrani; David B Goldstein; Rui Xiao; Yaping Yang; Jennifer E Posey; Julian A Martinez-Agosto; James R Lupski; Michael F Wangler; Vandana Shashi
Journal:  Am J Hum Genet       Date:  2017-01-26       Impact factor: 11.043

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.